Paper
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.
Published Dec 15, 2012 · Y. Terao, Hideo Suzuki, M. Yoshikawa
Bioorganic & medicinal chemistry letters
Q2 SJR score
56
Citations
2
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Imidazo[1,2-a]pyridines are potent, selective, and orally bioavailable ASK1 inhibitors for a wide range of therapeutic targets.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability.
Imidazopyridazine 10 shows similar in vitro and in vivo efficacy to 1, but with minimal deacetylated metabolite in hepatocytes, improving metabolic stability for PI3K/mTOR dual inhibitors.
2011·38citations·Markian M Stec et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1).
NQDI-1 shows potential as a selective inhibitor of ASK1 for treating cardiac and neurodegenerative disorders.
2011·61citations·G. Volynets et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
The influence of drug-like concepts on decision-making in medicinal chemistry
Drug-like concepts, such as the 'rule of five', can reduce attrition in drug discovery and development, but recent trends in lipophilicity may increase attrition and require a broader approach to medicinal chemistry decision-making.
2007·2026citations·P. Leeson et al.·Nature Reviews Drug Discovery
Nature Reviews Drug Discovery
Pathophysiological roles of ASK1-MAP kinase signaling pathways.
ASK1-MAPK pathways play a role in the pathogenesis of various human diseases, suggesting potential therapeutic targets for various human diseases.
2007·239citations·H. Nagai et al.·Journal of biochemistry and molecular biology
Journal of biochemistry and molecular biology
Apoptosis Signal-Regulating Kinase 1 Mediates Cellular Senescence Induced by High Glucose in Endothelial Cells
High glucose accelerates endothelial cell senescence and upregulation of PAI-1 expression, making ASK1 a potential therapeutic target to prevent vascular ageing and thrombosis in diabetic patients.
2006·160citations·T. Yokoi et al.·Diabetes
Diabetes
Citations
Modulating the phosphorylation status of target proteins through bifunctional molecules.
Phosphorylation-regulating bifunctional molecules (PBMs) promote the spatial proximity of target proteins to kinases/phosphatases, altering their phosphorylation state and potentially benefiting various diseases.
2025·0citations·Qi He et al.·Drug discovery today
Drug discovery today
Design of bifunctional molecules to accelerate post-translational modifications: achievements and challenges.
Bifunctional molecules show promise in targeting post-translational modifications, but challenges in effector selection and ligand design strategies remain.
2024·0citations·Yuxuan Wang et al.·Drug discovery today
Drug discovery today
Prediction of apoptosis signal-regulating kinase 1 (ASK1) inhibition with machine learning methods
Combining various descriptors improves predictive ability of ASK1 inhibitory activity, with traditional machine learning models showing no advantage in low-data scenarios.
2024·0citations·Zheng-Kun Kuang et al.·Chemical Papers
Chemical Papers
TGFβ1-driven SMAD2/3 phosphorylation and myofibroblast emergence are fully dependent on the TGFβ1 pre-activation of MAPKs and controlled by maternal leucine zipper kinase.
TGF-1's canonical pathway is fully subordinated to the MAPK pathway, and SMAD2/3 activation is mediated by MELK, challenging the concept of canonical and noncanonical TGF- pathways.
2023·3citations·Zhang Wang et al.·Cellular signalling
Cellular signalling
Synthesis, characterization, molecular docking, and biological evaluation of novel ASK1 inhibitors
Novel ASK1 inhibitors 44a and 44b show potent inhibitory activity and good safety in human normal liver cells, offering potential for future development as treatments for diseases like nonalcoholic steatohepatitis and multiple sclerosis.
2023·4citations·Hui Wang et al.·Journal of Molecular Structure
Journal of Molecular Structure
Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1.
Small-molecule inhibitors targeting ASK1 show potential in treating inflammation, cancer, and the nervous system.
2023·8citations·Tiantian Wang et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
Synthesis of polyfunctionalized imidazopyridine carbonitrile and pyridopyrimidine carbothioamide derivatives
This one-pot method for synthesis of polyfunctionalized imidazopyridine carbonitrile and pyridopyrimidine carbothioamide derivatives offers easy access to reactants, mild conditions, and simple workup and purification procedures.
2023·0citations·Samiyeh Yosefdad et al.·Monatshefte für Chemie - Chemical Monthly
Monatshefte für Chemie - Chemical Monthly
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity.
DDO3711, a PP5-recruiting PHORC, effectively accelerates dephosphorylation of p-ASK1T838 and shows antiproliferative activity against MKN45 cells, offering potential for precise phosphorylation regulation in oncoproteins.
2022·28citations·Qiuyue Zhang et al.·Journal of the American Chemical Society
Journal of the American Chemical Society